A systematic review of Tuina for irritable bowel syndrome: Recommendations for future trials
- 1 August 2020
- journal article
- review article
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 52, 102504
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81830115)
- Ministry of Education of the People's Republic of China (MS200800090)
- Beijing University of Chinese Medicine
This publication has 14 references indexed in Scilit:
- Rome IV—Functional GI Disorders: Disorders of Gut-Brain InteractionGastroenterology, 2016
- Novel pharmacological therapies for irritable bowel syndromeExpert Review of Gastroenterology & Hepatology, 2016
- Irritable Bowel SyndromeJAMA, 2015
- American Gastroenterological Association Institute Guideline on the Pharmacological Management of Irritable Bowel SyndromeGastroenterology, 2014
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT StatementJournal of Evidence-Based Medicine, 2010
- Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic TreatmentsAnnals of Internal Medicine, 2008
- Costs of Irritable Bowel Syndrome in the UK and USPharmacoEconomics, 2006
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Funnel plots for detecting bias in meta-analysisJournal of Clinical Epidemiology, 2001